IOP, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.971
AS - Asia 2.428
EU - Europa 1.732
AF - Africa 635
SA - Sud America 536
OC - Oceania 79
Continente sconosciuto - Info sul continente non disponibili 25
Totale 11.406
Nazione #
US - Stati Uniti d'America 5.633
SG - Singapore 908
CN - Cina 523
IT - Italia 344
BR - Brasile 336
HK - Hong Kong 291
DE - Germania 275
FI - Finlandia 200
VN - Vietnam 125
SE - Svezia 107
RU - Federazione Russa 78
GB - Regno Unito 72
FR - Francia 68
PL - Polonia 68
BJ - Benin 59
NL - Olanda 50
UA - Ucraina 47
CA - Canada 39
IN - India 39
MX - Messico 34
AR - Argentina 33
AT - Austria 32
CI - Costa d'Avorio 32
KR - Corea 31
ES - Italia 30
LA - Repubblica Popolare Democratica del Laos 30
IE - Irlanda 29
LC - Santa Lucia 26
ZA - Sudafrica 26
ID - Indonesia 25
EC - Ecuador 24
PH - Filippine 24
TR - Turchia 24
JP - Giappone 23
PY - Paraguay 23
IL - Israele 22
PA - Panama 22
BE - Belgio 21
IQ - Iraq 21
TN - Tunisia 21
AU - Australia 20
GA - Gabon 20
NC - Nuova Caledonia 20
PE - Perù 20
TT - Trinidad e Tobago 20
VE - Venezuela 20
AZ - Azerbaigian 19
BO - Bolivia 19
CM - Camerun 19
AL - Albania 18
BB - Barbados 18
IR - Iran 18
KG - Kirghizistan 18
KZ - Kazakistan 18
PK - Pakistan 18
SN - Senegal 18
AM - Armenia 17
BY - Bielorussia 17
CO - Colombia 17
CR - Costa Rica 17
DZ - Algeria 17
JM - Giamaica 17
ML - Mali 17
MU - Mauritius 17
PS - Palestinian Territory 17
PT - Portogallo 17
SA - Arabia Saudita 17
SI - Slovenia 17
UZ - Uzbekistan 17
AO - Angola 16
CG - Congo 16
EE - Estonia 16
GH - Ghana 16
GM - Gambi 16
JO - Giordania 16
LV - Lettonia 16
MR - Mauritania 16
BZ - Belize 15
CH - Svizzera 15
GF - Guiana Francese 15
NE - Niger 15
NG - Nigeria 15
NZ - Nuova Zelanda 15
TJ - Tagikistan 15
UY - Uruguay 15
AE - Emirati Arabi Uniti 14
CL - Cile 14
CU - Cuba 14
EG - Egitto 14
GP - Guadalupe 14
GR - Grecia 14
LU - Lussemburgo 14
NI - Nicaragua 14
PR - Porto Rico 14
SD - Sudan 14
ZW - Zimbabwe 14
AD - Andorra 13
BF - Burkina Faso 13
BG - Bulgaria 13
CD - Congo 13
Totale 10.793
Città #
Fairfield 805
Ashburn 572
Woodbridge 524
Singapore 512
Chandler 436
Ann Arbor 364
Houston 322
Seattle 296
Hong Kong 281
Wilmington 273
Cambridge 261
Beijing 175
Munich 160
Boardman 133
Padova 131
Jacksonville 119
Helsinki 109
Santa Clara 104
Princeton 82
Los Angeles 70
San Diego 70
Cotonou 58
Medford 57
Des Moines 54
Nanjing 48
New York 42
Roxbury 37
Bytom 36
São Paulo 34
Ho Chi Minh City 33
Abidjan 31
Hanoi 30
Turku 28
Chicago 27
Vientiane 27
Hefei 26
Castries 24
Dublin 24
Guangzhou 22
Milan 21
Libreville 20
Noumea 20
Vienna 19
Brooklyn 18
Dakar 18
Nuremberg 18
Rome 18
Baku 17
Bishkek 17
Dallas 17
Amman 16
Nouakchott 16
Panama City 16
Stockholm 16
Bamako 15
Buffalo 15
Dushanbe 15
Montreal 15
Redondo Beach 15
Rio de Janeiro 15
Warsaw 15
Yerevan 15
Bridgetown 14
Johannesburg 14
Luanda 14
Niamey 14
Seoul 14
Shenyang 14
Tokyo 14
Amsterdam 13
Andorra la Vella 13
Denver 13
Kigali 13
London 13
Lusaka 13
Managua 13
Minsk 13
Montevideo 13
Praia 13
Riga 13
Shanghai 13
Tashkent 13
Tunis 13
Yaoundé 13
Accra 12
Havana 12
Jinan 12
San José 12
Tirana 12
Antananarivo 11
Asunción 11
Conakry 11
Harare 11
Hebei 11
Kampala 11
Kinshasa 11
Lima 11
Nairobi 11
Ouagadougou 11
Phnom Penh 11
Totale 7.298
Nome #
A Comprehensive Comparison of Bovine and Porcine Decellularized Pericardia: New Insights for Surgical Applications 338
A Sterilization Method for Decellularized Xenogeneic Cardiovascular Scaffolds 261
Human bone marrow-derived CD133+ cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis. 240
The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. 225
Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery 214
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 211
Bioengineered percutaneous heart valves for transcatheter aortic valve replacement: a comparative evaluation of decellularised bovine and porcine pericardia 208
Decellularized aortic conduits: could their cryopreservation affect post-implantation outcomes? A morpho-functional study on porcine homografts 207
Multimodal label-free ex vivo imaging using a dual-wavelength microscope with axial chromatic aberration compensation 207
Decellularized Allogeneic Heart Valves Demonstrate Self-Regeneration Potential after a Long-Term Preclinical Evaluation 205
Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. 200
RegenHeart: A Time-Effective, Low-Concentration, Detergent-Based Method Aiming for Conservative Decellularization of the Whole Heart Organ 199
Guided Tissue Regeneration in Heart Valve Replacement: From Preclinical Research to First-in-Human Trials 196
Nanopatterned acellular valve conduits drive the commitment of blood-derived multipotent cells 190
The Rapidly Evolving Concept of Whole Heart Engineering 190
Preservation strategies for decellularized pericardial scaffolds for off-the-shelf availability 187
Alpha-Gal detectors in xenotransplantation research: a word of caution. 183
Decellularized Cryopreserved Allografts as Off-the-Shelf Allogeneic Alternative for Heart Valve Replacement: In Vitro Assessment Before Clinical Translation 182
In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves 177
Native Bovine and Porcine Pericardia Respond to Load With Additive Recruitment of Collagen Fibers 176
Mechanical testing of pericardium for manufacturing prosthetic heart valves 174
The vietnamese pig as a translational animal model to evaluate tissue engineered heart valves: Promising early experience 174
First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. 170
Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts 169
The Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine 167
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat 164
The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration 164
Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity 161
Covalent functionalization of decellularized tissues accelerates endothelialization 160
Biocompatibility Evaluation Criteria for Novel Xenograft Materials: Distribution and Quantification of Remnant Nucleic Acid and Alpha-Gal Epitope 156
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile. 153
First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. 152
Fibrosis in tissue engineering and regenerative medicine: treat or trigger? 151
Spontaneous coronary artery dissection in women with acute myocardial infarction: is there a new role for autoimmunity? 151
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. 150
Hybrid membranes for the production of blood contacting surfaces: physicochemical, structural and biomechanical characterization 146
Decellularized Porcine Aortic Roots: Histopathology Features in an Experimental Animal Model of Right Ventricular Outflow Tract Reconstruction 143
AUTOANTIBODIES TARGETING ENDOTHELIN TYPE-A AND ANGIOTENSIN TYPE-1 RECEPTORS ASSOCIATE WITH RISK OF MICROVASCULAR OBSTRUCTION AFTER STEMI 142
Xenotransplantation: The Way beyond and Ahead toward Clinical Application 137
Association of autoantibodies targeting endothelin type-A receptors with no-reflow in ST-elevation myocardial infarction 136
The Biocompatibility Challenges in the Total Artificial Heart Evolution 134
Stem Cell Populations in Human Heart Valves: Identification, Isolation and Characterization in Valve Homografts and Surgical Specimens. 133
Biocompatibility Issues of Next Generation Decellularized Bioprosthetic Devices 130
Bioengineering the Cardiac Conduction System: Advances in Cellular, Gene, and Tissue Engineering for Heart Rhythm Regeneration 128
Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: Implications for aortic valve calcification 127
Are FDA and CE sacrificing safety for a faster commercialization of xenogeneic tissue devices? Unavoidable need for legislation in decellularized tissue manufacturing 123
Angiotensin II and Atherosclerosis: A New Cardiovascular Risk Factor Beyond Hypertension 118
From the anatomical study to the application of different bioengineering techniques for the creation of new vital heart valve substitutes 116
Association of Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Agonistic Autoantibodies With Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction 115
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile 114
Mechanical Circulatory Support and Stem Cell-Based Heart Treatment in Europe—2018 Clinical Update 114
Advances in the design, generation, and application of tissue-engineered myocardial equivalents 113
NEW ALPHA-GAL REMOVAL ASSAY: PRESENCE AND DISTRIBUTION OF THE EPITOPE BEFORE AND AFTER CELL REMOVAL FROM XENOGENEIC HEART VALVES 110
Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: Lessons from preclinical modeling 109
Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies 108
Tissue-Guided Regenerated Valved Conduits: Long-Term Results of Porcine Decellularized alpha-Gal Negative Roots 106
Novel heart valve replacement solutions based on self-assembling peptide-functionalized acellular pericardium 103
Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy 101
Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction 101
Time-course evaluation of tissue engineered valved conduits:long term results of porcine decellularized alpha-Gal- valves. 99
Spontaneous cell repopulation of valved conduits after decellularization and allogeneic transplantation 98
FLOGISTIC AND BIOCOMPATIBILITY EFFECTS DETERMINATION OF DECELLULARIZED AND COMMERCIAL AVAILABLE AORTIC LEAFLETS AFTER IMPLANTATION IN A PERITONEAL EXPERIMENTAL RAT MODEL 96
Alpha-Gal Removal Tool for the Creation of Xenogenic Biocompatible Heart Valve 96
Ischemia sperimentale coronarica nel suino: variazioni anestesiologiche e indotte. 95
New Generation Devices for Transcatheter Aortic Valve Implantation 94
Novel heart valve replacement solutions based on self-assembling peptide-functionalized acellular pericardium. 93
Editorial: Insight in heart valve disease: 2021 92
Hybrid membranes for blood-contacting surfaces: preliminary characterization 91
Antibodies against angiotensin II type 1 and endothelin-1 type A receptors are associated with microvascular obstruction after revascularized ST-elevation myocardial infarction 90
Endotoxin and phosphate may contribute to valve calcification by inducing an osteogenic profile in a specific subset of interstitial aortic valve cells 89
Modeling Cardiac Congenital Diseases: From Mathematic Tools to Human Induced Pluripotent Stem Cells 85
Editorial: Vascular and valvular tissue engineering: Treating and modeling vasculopathies and valvulopathies 83
Abstract 12535: Spontaneous Coronary Artery Dissection in Women: A New Role for Autoimmunity? 80
Cutting-Edge Regenerative Medicine Technologies for the Treatment of Heart Valve Calcification (Chapter 9) 80
In Vivo Spontaneous Tissue Regeneration Of Allogeneic Decellularized Aortic Valves. 78
Popolazioni cellulari staminali nelle valvole cardiache umane: identificazione, isolamento e caratterizzazione in homograft valvolari e campioni chirurgici 78
Present and future perspectives on total artificial hearts 77
Editorial: Tissue and organ decellularization strategies in regenerative medicine; recent advances, current translational challenges, and future directions 75
Abstract 12646: Autoantibodies Targeting Endothelin Type-A Receptors Associate With no Reflow After ST-elevation Myocardial Infarction 70
Biocompatibility Evaluation Criteria for Novel Xenograft Materials: Distribution and Quantification of Remnant Nucleic Acid and Alpha-Gal Epitope 70
Evaluation of Decellularized Aortic Valve Leaflets Biocompatibility in a rat model 67
Cellular, molecular, genomic changes occurring in the heart under mechanical circulatory support. 65
Abstract 12559: Functional Autoantibodies Against Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Predict Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction 53
Prognostic role of angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with acute myocardial infarction 49
Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades? 27
Totale 11.589
Categoria #
all - tutte 35.904
article - articoli 31.761
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 771
Totale 68.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021632 0 0 0 0 42 42 16 71 151 161 92 57
2021/20221.024 28 91 96 181 42 63 46 134 54 9 69 211
2022/2023852 151 107 31 111 117 112 4 64 91 3 50 11
2023/2024416 19 66 47 41 23 29 28 25 20 25 40 53
2024/20252.077 10 115 77 94 244 99 169 187 206 72 326 478
2025/20263.919 417 639 1.076 1.331 456 0 0 0 0 0 0 0
Totale 11.589